1. Inhaled nitric oxide reduces human lung allograft dysfunction
Hiroshi Date, MD, Anastosios N. Triantafillou, MD, Elbert P. Trulock, MD, Mary S. Pohl, RN, BSN, Joel D. Cooper, MD, G.Alexander Patterson, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 111, Issue 5, Pages (May 1996)
DOI: /S (96)
Copyright © 1996 Mosby, Inc. Terms and Conditions

2. Fig. 1
Pao2/Fio2 ratio before (BL, baseline) and after nitric oxide treatment. Statistical analysis was performed on the data obtained during the first 8 hours because of the different durations of nitric oxide (NO) therapy in each case. *p < 0.05, **p < 0.01 (versus baseline).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Mosby, Inc. Terms and Conditions

3. Fig. 2
Mean pulmonary artery (PA) pressure before (BL, baseline) and after nitric oxide (NO) treatment. Statistical analysis was performed on the data obtained during the first 8 hours because of the different durations of nitric oxide therapy in each case. *p < 0.05 (versus baseline).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Mosby, Inc. Terms and Conditions